← All stocks

MAXCYTE, INC.

MXCT No buying or selling
CIK 0001287098 #4148 in the set updated 22 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

13 insiders · 0 transactions
0.6×

Maher Masoud holds only 0.6 times base salary in stock. $387.13K of shares against $590.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Maher Masoud last reported holding, valued at $0.82, the price Common Stock was last bought or sold at on the open market here, on 17 Mar 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Masoud Maher
President and CEO
475,000
$387.13K
+375.0%
Erck Stanley C
Director
428,749
$349.43K
+59.3%
DOUGLAS RICHARD
Director
260,998
$212.71K
+115.0%
Johnston John Joseph
Director
201,581
$164.29K
+42.0%
Ahuja Parmeet
Chief Financial Officer
187,500
$152.81K
Brooke William W
Director
181,300
$147.76K
+153.0%
Swirsky Douglas J
CHIEF FINANCIAL OFFICER
151,669
$123.61K
+86.7%
Collins Cynthia
Director
111,310
$90.72K
BALTHROP PATRICK J
Director
80,998
$66.01K
+279.1%
Al-Wakeel Yasir B.
Director
80,998
$66.01K
+279.1%
Hemrajani Rekha
Director
70,314
$57.31K
+229.1%
Sandoval David I.
GENERAL COUNSEL
64,219
$52.34K
+39.9%
Soleymannezhad Ali
Chief Commercial Officer
59,439
$48.44K
+128.4%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 0
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 3 Aug 2021